Navigation Links
ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
Date:6/19/2008

MEMPHIS, Tenn., June 19 /PRNewswire/ -- Accelerated Community Oncology Research Network(TM) (ACORN) will be showcasing its oncology-focused CRO and research network; Guardian EDC(TM); PACE(TM) PRO System; and proprietary oncology-focused data warehouse at the 44th Annual DIA Meeting, June 22-26, in Boston, MA.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )

In March, 2008 the company announced its Contract Research Organization (CRO) exceeded performance expectations over the previous 12 months. ACORN's CRO provides a full-range of research services to sponsors, from clinical trial design to site selection to the results phase with bioanalysis and findings presentation. ACORN's member network provides core strength to CRO operations and is recognized for its exceptional recruitment of minority trial participants at more than double the national average.

With the company's recent announcement that its Oncology Data Warehouse accumulated nearly 50 million data observations from over 110,000 oncology patients in its data warehouse, ACORN(TM) is poised as a leader in providing reliable information solutions to payers, financial institutions, pharmaceutical / biotech companies, and community oncology practices.

Additionally, ACORN's accrual of over one million comprehensive physical and psychological cancer patient assessments obtained via PACE(TM) (Patient Assessment Care and Education) and continued market uptake of Guardian EDC(TM) (web-based electronic data capture) demonstrates its continued leadership in capturing unique electronic data into a single platform for easy access across the full range of data elements and conducting scientific analysis to generate reliable information solutions in the oncology industry.

Analytical data from ACORN's oncology data repository has been presented at many major oncology-related conferences and published in peer-reviewed medical journals worldwide. Furthering the field of oncology health informatics, ACORN's Oncology Data Warehouse has been used in numerous projects that address quality of care, patients' quality of life, overall health outcomes and the cost of care.

Senior-level executives will be available to discuss ACORN's Oncology Data Warehouse, CRO services, Guardian EDC(TM), and network of community oncology practices in Booth # 239 at DIA's 44th Annual Meeting in Boston, MA, June 22-25, 2008. For additional information visit http://www.ACORNresearch.net or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.

Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Contract Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

lconway@sosacorn.com

http://www.ACORNresearch.net

Deborah D. Coble

901-683-0055x1312

Cell: 901-831-1010

dcoble@sosacorn.com


'/>"/>
SOURCE Accelerated Community Oncology Research Network, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. ACORNs Oncology-focused Contract Research Organization Exceeds Projections
2. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
3. ACORN Continues Success in Oncology Data Warehousing With Accumulation of Nearly 50 Million Data Observations
4. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
5. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
6. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
10. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
11. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
Breaking Medicine Technology:
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... ... Cal Dining at the University of California Berkeley, and other leading institutions in ... the buying power of institutions to change the way animals are raised for ...
Breaking Medicine News(10 mins):